Results for “ ”

Entry Author Date Location
Nearpod, A Pioneer of VR in Edtech, Raises $21M 03/01/17 San Francisco
Wall Street Bets $50M on Kensho’s A.I. Investing Tools 03/01/17 Boston
Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M 03/01/17 San Francisco
Former FDA Commissioners Califf, McClellan Talk Healthcare’s Future 03/01/17 National
Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne Treatment 02/27/17 Boston
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy 02/27/17 New York
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Bowery Bags $7.5M to Break Into Fast-Growing Indoor Farming Market 02/23/17 New York
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Rackspace Spinout Mailgun Raises $50M for API-Focused E-mail Service 02/22/17 Texas
Sexual Harassment Claims Add to Turbulent Times for Uber 02/22/17 San Francisco
Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M 02/22/17 New York
Amazon, Uber, and Bill Gates’s Robot Tax: An Automation Snapshot 02/22/17 National
Cashing in On Duchenne Approval, Sarepta Sells Voucher to Gilead For $125M 02/21/17 Boston
Boston, NY Tech Job Growth Hits 5-Year Low, as Amazon Keeps Expanding 02/21/17 Boston
Lumina Foundation Gives Odds For Edtech Innovation Under Trump 02/20/17 San Francisco
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision? 02/16/17 New York
Fintech VC Backing Dipped 13 Percent in 2016, Mirroring Rest of Tech 02/15/17 New York
Merck Alzheimer Drug Is Latest To Fail In A Big Study 02/15/17 National
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Allergan to Acquire Fat-Busting Medical Tech Firm Zeltiq for $2.4B 02/13/17 San Francisco
Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights 02/10/17 Seattle
Senate Confirms Price for HHS, But Stock Deals Still Raise Questions 02/10/17 National
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs 02/10/17 Boston
Bio Roundup: Travel Ban Block, Gilead Shock, Dean Kamen Talk & More 02/10/17 National
Often Advocates Of Faster FDA, Patient Groups Wary Of Trump Deregulation 02/10/17 National
San Francisco Appeals Court Upholds Stay on Trump’s Travel Ban—For Now 02/09/17 National
Xconomy Is Growing: We Need Great Salespeople in SF, Texas, and NY 02/09/17 National
Page 2 of 106 « previous page · next page »